Announcement at noon: BGI’s self-test product for COVID-19 antigen has been granted CE approval in the European Union

2022-04-25 0 By

On February 7, CFNA announced that its wholly-owned subsidiary has been granted CE approval for its novel Coronavirus antigen self-test product, which is used for in vitro qualitative detection of Novel Coronavirus (SARS-COV-2) in nasal swab samples of suspected cases of novel Coronavirus infection within 7 days of the onset of infection, to assist evaluation of novel Coronavirus infection status and clinical diagnosis.Suitable for home self-examination.Construction and repair announcement: Won the bidding for dolphin rubber patch restoration and treatment project, with the winning amount of 317 million yuan, accounting for 30.53% of the company’s annual revenue in 2020, and the construction period will be 18 months.Codali announcement, public issuance of convertible bond application accepted by the SFC.Photonics technology announcement, non-public offering of shares by the CSRC application.Shunbo Alloy announced that it received government subsidy of 27.2808 million yuan in January, among which the government subsidy related to income was confirmed to be 26.9883 million yuan.Author’s latest article 1 million doses per day!Canada’s capital, Ottawa, is in a state of emergency. Japan is set to approve a novel coronavirus oral drug for sale in 2021.China will speed up the construction of a recycling system for used materials.The total box office of new films hit 6 billion yuan during the Spring Festival.Zulu’s Rule: Use these three criteria to pick the strongest portfolio!Disclaimer: This article is reproduced for the purpose of conveying more information.If the source is wrong or violated your legitimate rights and interests, please contact the author with proof of ownership, we will promptly correct, delete, thank you.Email address: newmedia@xxcb.cn